CanSino Biologics Inc.

General ticker "CASBF" information:

  • Sector: Health Care
  • Industry: Drug Manufacturers - Specialty & Generic
  • Capitalization: $1.1B (TTM average)

CanSino Biologics Inc. follows the US Stock Market performance with the rate: 19.3%.

Estimated limits based on current volatility of 0.9%: low 3.95$, high 4.01$

Factors to consider:

  • Price in estimated range
  • Earnings for 3 months up through Q1 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

  • 2025-12-31 to 2026-12-31 estimated range: [3.08$, 6.13$]
  • 2026-12-31 to 2027-12-31 estimated range: [2.80$, 5.63$]

Similar symbols

Short-term CASBF quotes

Long-term CASBF plot with estimates

Financial data

YTD 2023-12-31 2024-12-31 2025-12-31
Operating Revenue CNY345.18MM CNY824.88MM CNY1,032.05MM
Operating Expenses CNY2,380.36MM CNY1,228.27MM CNY1,145.18MM
Operating Income CNY-2,035.18MM CNY-403.39MM CNY-113.13MM
Non-Operating Income CNY56.30MM CNY22.19MM CNY134.31MM
Interest Expense CNY64.14MM CNY59.98MM CNY55.81MM
R&D Expense CNY637.99MM CNY416.12MM CNY0.00MM
Income(Loss) CNY-1,978.88MM CNY-381.20MM CNY21.18MM
Taxes CNY11.45MM CNY2.47MM CNY-5.98MM
Profit(Loss)* CNY-1,482.73MM CNY-378.88MM CNY27.15MM
Stockholders Equity CNY5,274.60MM CNY4,909.87MM CNY4,956.12MM
Inventory CNY352.85MM CNY280.52MM CNY338.48MM
Assets CNY9,318.77MM CNY7,958.13MM CNY7,185.23MM
Operating Cash Flow CNY-908.23MM CNY-168.79MM CNY32.49MM
Capital expenditure CNY610.47MM CNY457.64MM CNY185.33MM
Investing Cash Flow CNY-449.65MM CNY3.96MM CNY355.39MM
Financing Cash Flow CNY-7.58MM CNY-334.18MM CNY-703.08MM
Earnings Per Share** CNY-6.01 CNY-1.53 CNY0.11

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.